🔗 Share this article

Given that the US continues making unprecedented adjustments to its vaccine recommendations, a particular individual appears in a surprising turn: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and epidemiologist who first made her name by expressing skepticism about COVID-19 vaccines during the pandemic and has concentrated on potential fatalities following Covid vaccination in her recent time at the FDA.

Scheduled Overhauls to Childhood Immunization Program

Public health authorities had intended to announce sweeping revisions to the pediatric vaccination calendar recently, aligning the US with Denmark’s national calendar, according to reports – a significant shift that would place the US out of alignment with a large portion of the world with no evidence for public health gain. This reveal has been postponed until the coming year.

Instead of the director of the vaccine center, Dr. Høeg is scheduled to present at the gathering. She was newly appointed acting director of the FDA’s CDER, the fifth appointee to head the center this calendar year.

A Shift at the Regulatory Body

The acting appointment might represent a strengthened alliance between the pharmaceutical and biologics divisions as Dr. Høeg and Dr. Prasad solidify control at the regulatory agency – and it signals a increased emphasis upon dismantling long-standing vaccines at the FDA.

Høeg has frequently advocated for halting specific pediatric immunization guidelines in the US in order to be more in line with Denmark, a country with nationalized medicine and a citizenry about the population of the state of Wisconsin.

In her initial statements, she has persisted in emphasizing on vaccination policy – usually the purview of Dr. Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than drug regulation.

Questions Over Qualifications

The appointee has no apparent background in medication creation, approval processes or leadership, which has been standard for previous directors of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a top consultant to the agency head and the vaccine center since earlier this year.

“She doesn’t seem to have the requisite experience” for overseeing the CDER, said Jonathan Howard. “She has not conducted a clinical trial. She has no expertise in leading a major agency. She has no expertise in industry regulation.”

Previous heads of the center would “be deeply familiar with regulatory frameworks and the science of pharmaceutical innovation”, commented Janet Woodcock. “Frankly, she has not acquired the sort of resume that former directors who headed the center have had.”

CDER has an vast range of responsibilities at the agency, the former commissioner pointed out.

“Many people just pays attention on the novel medication approvals, but the off-patent medication office clears a multitude of off-brand pharmaceuticals. There’s a biologic copycat branch, OTC medication office and so forth, and each of these must be managed,” Dr. Woodcock said. “The responsibility you overlook, that is precisely what that I always told people is going to come back to haunt you.”

There is also, a substantial leadership aspect to the job, which oversees in excess of 5,000 staff members. “It is a massive leadership role, if you perform it correctly,” Woodcock added.

Agency Reaction and Disputed Policies

Regarding concerns about Dr. Høeg's credentials and whether this assignment represents more teamwork among regulatory chiefs on vaccines, a press secretary stated that the “concerns rely on inaccurate premises”.

“Her experience aligns with the functions of her role,” the representative stated, pointing to the time Høeg spent advising the FDA commissioner on “medication safety and approval science, including computational safety modeling and shot safety tracking”.

In her interim role, Dr. Høeg assumes responsibility for the agency head's new expedited review system, a contentious expedited drug-approval program that apparently troubled her former heads. “By what process are these drugs being picked for this expedited pathway? Who takes the choices?” Dr. Howard questioned. “There’s a lot of confidentiality going on at the agency right now.”

Broadly speaking, he remarked, “the agency looks to be trending towards laxer rules of pharmaceuticals, with the exception of immunizations.”

Public Past Work on Vaccines

Regarding vaccines, Høeg has a more established, if troubling, past, Howard have noted. She published a analysis using unconfirmed crowd-sourced reports to determine the incidence of myocarditis after COVID-19 immunization. She counseled the state of Florida top health official Dr. Joseph Ladapo, who allegedly have altered data to indicate Covid vaccinations are more dangerous than they are.

Part of her “wish list” for the new federal leadership encompassed altering guidelines for recently developed shots and discontinuing “optional” vaccines, she stated post-election on a audio program. At the agency, Dr. Høeg has reportedly floated the idea of excluding teenage boys from obtaining COVID-19 vaccinations.

“She is an complete true believer who starts off with her preconceived notions and tailors the evidence to accommodate the science in a very disingenuous, fraudulent manner,” Dr. Howard said.

Gaining Influence and a “Campaign of Retribution”

Dr. Høeg joined fellow skeptics, {like|